How Adding a Clinical Pharmacist Improves Access to Addiction Care (On-Demand)-Recording Presentation

Video Transcription

Video Summary

In this video, Dr. Allison Lynch and Ben Miskell discuss the role of clinical pharmacists in the treatment of substance use disorders. They introduce their Addiction and Recovery Collaborative at the University of Iowa and highlight their Medications for Addiction Treatment (MAT) Clinic. They explore the educational goals of healthcare professionals working with patients with substance use disorders and the impact of pharmacists on patient care outcomes. The presenters discuss a case study of a patient seeking treatment for opioid use disorder and explain how a pharmacist can assist in addressing the patient's concerns and challenges. They mention the benefits of having a pharmacist on the team, including providing patient education, assisting with medication management, collaborating with other healthcare professionals, and reducing workload for other team members. The presenters also discuss collaborative practice agreements between pharmacists and providers, how they can enhance care delivery, and provide examples of collaborative practices in different healthcare settings. They also touch on the financial implications and funding sources for having pharmacists on the team. The video concludes with a discussion of research studies that highlight the positive impact of clinical pharmacists in enhancing treatment and reducing workload burden. The presenters emphasize the importance of collaboration and interdisciplinary care to optimize care for patients with substance use disorders.

Keywords

clinical pharmacists

substance use disorders

Addiction and Recovery Collaborative

University of Iowa

Medications for Addiction Treatment (MAT) Clinic

patient care outcomes

pharmacist's role

collaborative practice agreements

interdisciplinary care